Data from the first-in-human radioligand-therapy for muscle invasive bladder cancer (MIBC) using Pentixapharm's Lu177-PentixaTher compound will be shown at the American Society of Clinical Oncology's ...
Monday – Thursday, noon – 1 p.m. Rebroadcast 7 p.m. – 8 p.m.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback